SOX2 and lung cancer: Furthermore, by assessing clinical samples of lung cancer brain metastatic patients from current and never smokers, we found significantly increased SOX2 and reduced SKI expression in brain metastatic tissue lesions of current smoker compared to never smokers (Supplementary Fig. 5J, K).